GB764715A - Stabilised solutions containing streptomycin - Google Patents

Stabilised solutions containing streptomycin

Info

Publication number
GB764715A
GB764715A GB22094/54A GB2209454A GB764715A GB 764715 A GB764715 A GB 764715A GB 22094/54 A GB22094/54 A GB 22094/54A GB 2209454 A GB2209454 A GB 2209454A GB 764715 A GB764715 A GB 764715A
Authority
GB
United Kingdom
Prior art keywords
per cent
solution
streptomycin
sodium
monothioglycerol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB22094/54A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB764715A publication Critical patent/GB764715A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Abstract

A high potency streptomycin solution stabilized against discolouration and deterioration comprises an aqueous solution of a streptomycin salt, especially the sulphate, having a pH of 5.0 to 6.5 and containing as stabilizing components in the amount of 0.1 to 1.0 per cent, at least one substance selected from the group consisting of monothioglycerol, monothiosorbitol and monothioglucose, and in the amount of 0.1 to 2.5 per cent at least one substance selected from the group consisting of salts of sulphurous and hydrosulphurous acids and aldehyde-addition products thereof. Total stabilizer is 0.5 to 1.5 per cent. A mixture of monothioglycerol and sodium bisulphite in proportions of 0.2 to 0.7 and preferably 0.5 per cent of the former and 0.25 to 0.75, and preferably 0.25 per cent of the latter is employed. Other specified stabilizers of the salt of sulphurous acid type are sodium hydrosulphite, potassium bisulphite, potassium metabisulphite and sodium formaldehyde sulphoxylate. The pH of the solution is adjusted to the desired pH by means of a buffer such as sodium citrate. A preservative such as phenol may also be present: optional additions are (a) dihydrostreptomycin or other therapeutically active substances, especially penicillin salts; and (b) flavouring substances, in the case of oral preparations. Potency is 400 to 600 mg. streptomycin base per ml. of solution. Specification 684,459 is referred to.ALSO:A high potency streptomycin solution stabilized against discolouration and deterioration comprises an aqueous solution of a streptomycin salt especially the sulphate, having a pH of 5.0 to 6.5 and containing as stabilizing components in the amount of 0.1 to 1.0 per cent, at least one substance selected from the group consisting of monothioglycerol, monothiosorbitol and monothioglucose, and in the amount of 0.1 to 2.5 per cent at least one substance selected from the group consisting of salts of sulphurous and hydrosulphurous acids and aldehyde-addition products thereof. Total stabilizer is 0.5 to 1.5 per cent. A mixture of monothioglycerol and sodium bisulphite in proportions of 0.2 to 0.7 and preferably 0.5 per cent of the former and 0.25 to 0.75, and preferably 0.25 per cent of the latter is employed. Other specified stabilizers of the salt of sulphurous acid type are sodium hydrosulphite, potassium bisulphite, potassium metabisulphite and sodium formaldehyde sulphoxylate. The pH of the solution is adjusted to the desired pH by means of a buffer such as sodium citrate. A preservative such as phenol may also be present: optional additions are (a) dihydrostreptomycin or other therapeutically active substances especially penicillin salts and (b) flavouring substances, in the case of oral preparations. Potency is 400 to 600 mg streptomycin base per ml of solution. Specification 684,459 is referred to.
GB22094/54A 1953-08-07 1954-07-28 Stabilised solutions containing streptomycin Expired GB764715A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US764715XA 1953-08-07 1953-08-07

Publications (1)

Publication Number Publication Date
GB764715A true GB764715A (en) 1957-01-02

Family

ID=22132247

Family Applications (1)

Application Number Title Priority Date Filing Date
GB22094/54A Expired GB764715A (en) 1953-08-07 1954-07-28 Stabilised solutions containing streptomycin

Country Status (1)

Country Link
GB (1) GB764715A (en)

Similar Documents

Publication Publication Date Title
GB1287673A (en) Injectable compositions
ES355675A1 (en) Organic complex ferric compounds
GB1389621A (en) Salts of 3-hydroxy-2-hydroxy-methyl-propanesulphonic acid-1 and a process for their preparation
GB764715A (en) Stabilised solutions containing streptomycin
GB997633A (en) Improvements in or relating to nitrofurfurylideneamino-hydantoins
GB748024A (en) Improved therapeutic preparations of iron
GB1294299A (en) Isoniazid derivative
GB684459A (en) A stable aqueous solution of dihydrostreptomycin and method of preparing same
US2643998A (en) Stable antibiotic solutions
GB816592A (en) A method for the preparation of stable magnesium solutions of high concentration
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
GB770075A (en) Improvements in or relating to preparation of a fibrinogen product and stable solutions thereof
ES395433A1 (en) Stable aqueous pyritinol solutions
GB1415709A (en) Chlorinated mandelamidines
US3546205A (en) Stabilizing method and the preparation stabilized thereby
GB748857A (en) Process for the making of adrenocorticotrophin (acth) preparations having a prolonged action from acth with high specific activity
US2434625A (en) Preparation of alkali metal ascorbates
US2611732A (en) Compositions containing mixtures of 4-aminosalicylic acid and its basic calcium salt
GB715976A (en) Improvements in medical preparations for removing toxic heavy metals from the human body
GB1033378A (en) Stable injectable protamine-active solutions
GB1033736A (en) Stable injectable protamine-active compositions
ES391536A1 (en) Procedure for obtaining antibacterial compositions. (Machine-translation by Google Translate, not legally binding)
GB1276589A (en) 0-alkyl-6-azauracil compounds and compositions containing the same
GB750232A (en) Stabilisation of streptomycin
ES264781A1 (en) Improvements in or relating to the production of bactericidal sugar preparations